Dr. Reddy's Laboratories Limited (DRREDDY.NS)
INR 1116.65
(-0.32%)
INR 1116.65
(-0.32%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 63.55 Billion INR | 30.58% |
| 2022 | 48.67 Billion INR | -4.35% |
| 2021 | 50.88 Billion INR | 12.05% |
| 2020 | 45.41 Billion INR | 29.5% |
| 2019 | 35.06 Billion INR | 4.43% |
| 2018 | 33.57 Billion INR | 15.44% |
| 2017 | 29.08 Billion INR | 1.96% |
| 2016 | 28.52 Billion INR | 11.54% |
| 2015 | 25.57 Billion INR | 0.19% |
| 2014 | 25.52 Billion INR | 6.41% |
| 2013 | 23.99 Billion INR | -88.89% |
| 2012 | 215.99 Billion INR | 1016.14% |
| 2011 | 19.35 Billion INR | 20.51% |
| 2010 | 16.05 Billion INR | 20.1% |
| 2009 | 13.37 Billion INR | 1.1% |
| 2008 | 13.22 Billion INR | 18.8% |
| 2007 | 11.13 Billion INR | 47.19% |
| 2006 | 7.56 Billion INR | 9.42% |
| 2005 | 6.91 Billion INR | 97.52% |
| 2004 | 3.49 Billion INR | 15.19% |
| 2003 | 3.03 Billion INR | 9.55% |
| 2002 | 2.77 Billion INR | 26.53% |
| 2001 | 2.19 Billion INR | 14.61% |
| 2000 | 1.91 Billion INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 72.03 Billion INR | 5.06% |
| 2024 Q1 | 68.56 Billion INR | 7.89% |
| 2023 Q3 | 60.79 Billion INR | 7.43% |
| 2023 Q2 | 56.59 Billion INR | 8.0% |
| 2023 FY | 63.55 Billion INR | 30.58% |
| 2023 Q4 | 63.55 Billion INR | 4.53% |
| 2023 Q1 | 52.39 Billion INR | 7.66% |
| 2022 Q4 | 48.67 Billion INR | -1.33% |
| 2022 FY | 48.67 Billion INR | -4.35% |
| 2022 Q3 | 49.32 Billion INR | 0.58% |
| 2022 Q1 | 51.81 Billion INR | 1.82% |
| 2022 Q2 | 49.04 Billion INR | -5.34% |
| 2021 Q2 | 49.7 Billion INR | -2.11% |
| 2021 FY | 50.88 Billion INR | 12.05% |
| 2021 Q1 | 50.77 Billion INR | 11.8% |
| 2021 Q4 | 50.88 Billion INR | 2.43% |
| 2021 Q3 | 49.67 Billion INR | -0.05% |
| 2020 Q3 | 44.3 Billion INR | 7.72% |
| 2020 Q4 | 45.41 Billion INR | 2.49% |
| 2020 FY | 45.41 Billion INR | 29.5% |
| 2020 Q1 | 39.14 Billion INR | 11.64% |
| 2020 Q2 | 41.13 Billion INR | 5.07% |
| 2019 Q2 | 35.03 Billion INR | -0.3% |
| 2019 Q3 | 37.74 Billion INR | 7.74% |
| 2019 FY | 35.06 Billion INR | 4.43% |
| 2019 Q4 | 35.06 Billion INR | -7.1% |
| 2019 Q1 | 35.13 Billion INR | 4.64% |
| 2018 Q2 | 32.49 Billion INR | 3.15% |
| 2018 Q1 | 31.49 Billion INR | 8.28% |
| 2018 Q4 | 33.57 Billion INR | -0.98% |
| 2018 Q3 | 33.91 Billion INR | 4.37% |
| 2018 FY | 33.57 Billion INR | 15.44% |
| 2017 Q4 | 29.08 Billion INR | 8.44% |
| 2017 FY | 29.08 Billion INR | 1.96% |
| 2017 Q3 | 26.82 Billion INR | -0.64% |
| 2017 Q2 | 26.99 Billion INR | -3.9% |
| 2017 Q1 | 28.09 Billion INR | -1.52% |
| 2016 Q3 | 30.05 Billion INR | 5.39% |
| 2016 Q2 | 28.51 Billion INR | 2.13% |
| 2016 Q4 | 28.52 Billion INR | -5.07% |
| 2016 Q1 | 27.92 Billion INR | 9.16% |
| 2016 FY | 28.52 Billion INR | 11.54% |
| 2015 Q2 | 27.14 Billion INR | 3.82% |
| 2015 Q4 | 25.57 Billion INR | -4.16% |
| 2015 Q1 | 26.14 Billion INR | 2.43% |
| 2015 FY | 25.57 Billion INR | 0.19% |
| 2015 Q3 | 26.68 Billion INR | -1.69% |
| 2014 FY | 25.52 Billion INR | 6.41% |
| 2014 Q3 | 29.03 Billion INR | 3.25% |
| 2014 Q2 | 28.12 Billion INR | 11.07% |
| 2014 Q1 | 25.31 Billion INR | 5.53% |
| 2014 Q4 | 25.52 Billion INR | -12.08% |
| 2013 Q3 | 24.15 Billion INR | 1.16% |
| 2013 Q1 | 22.53 Billion INR | -89.57% |
| 2013 Q4 | 23.99 Billion INR | -0.65% |
| 2013 Q2 | 23.87 Billion INR | 5.94% |
| 2013 FY | 23.99 Billion INR | -88.89% |
| 2012 FY | 215.99 Billion INR | 1016.14% |
| 2012 Q4 | 215.99 Billion INR | 832.26% |
| 2012 Q2 | 21.88 Billion INR | 6.34% |
| 2012 Q1 | 20.58 Billion INR | 6.35% |
| 2012 Q3 | 23.16 Billion INR | 5.87% |
| 2011 FY | 19.35 Billion INR | 20.51% |
| 2011 Q4 | 19.35 Billion INR | -1.19% |
| 2011 Q3 | 19.58 Billion INR | 5.35% |
| 2011 Q2 | 18.59 Billion INR | 6.84% |
| 2011 Q1 | 17.4 Billion INR | 8.36% |
| 2010 Q1 | 14.45 Billion INR | 8.08% |
| 2010 Q3 | 15.24 Billion INR | 3.5% |
| 2010 Q4 | 16.05 Billion INR | 5.35% |
| 2010 FY | 16.05 Billion INR | 20.1% |
| 2010 Q2 | 14.72 Billion INR | 1.92% |
| 2009 Q3 | 12.9 Billion INR | -1.74% |
| 2009 Q1 | 13.93 Billion INR | 5.35% |
| 2009 Q4 | 13.37 Billion INR | 3.59% |
| 2009 Q2 | 13.13 Billion INR | -5.72% |
| 2009 FY | 13.37 Billion INR | 1.1% |
| 2008 FY | 13.22 Billion INR | 18.8% |
| 2008 Q4 | 13.22 Billion INR | -12.74% |
| 2008 Q1 | 13.04 Billion INR | 17.16% |
| 2008 Q2 | 15.37 Billion INR | 17.9% |
| 2008 Q3 | 15.15 Billion INR | -1.43% |
| 2007 Q4 | 11.13 Billion INR | 7.72% |
| 2007 Q3 | 10.33 Billion INR | 7.64% |
| 2007 Q2 | 9.6 Billion INR | 13.74% |
| 2007 Q1 | 8.44 Billion INR | 11.61% |
| 2007 FY | 11.13 Billion INR | 47.19% |
| 2006 Q3 | 8.56 Billion INR | -13.15% |
| 2006 Q4 | 7.56 Billion INR | -11.72% |
| 2006 Q1 | 8.8 Billion INR | 27.32% |
| 2006 FY | 7.56 Billion INR | 9.42% |
| 2006 Q2 | 9.86 Billion INR | 12.08% |
| 2005 FY | 6.91 Billion INR | 97.52% |
| 2005 Q3 | 4.38 Billion INR | 8.46% |
| 2005 Q4 | 6.91 Billion INR | 57.78% |
| 2005 Q1 | 3.66 Billion INR | 4.87% |
| 2005 Q2 | 4.03 Billion INR | 10.06% |
| 2004 Q4 | 3.49 Billion INR | 3.38% |
| 2004 FY | 3.49 Billion INR | 15.19% |
| 2004 Q1 | 3.3 Billion INR | 8.79% |
| 2004 Q3 | 3.38 Billion INR | -10.02% |
| 2004 Q2 | 3.76 Billion INR | 13.82% |
| 2003 Q1 | 2.89 Billion INR | 4.39% |
| 2003 Q4 | 3.03 Billion INR | -3.11% |
| 2003 Q2 | 3.13 Billion INR | 8.14% |
| 2003 Q3 | 3.13 Billion INR | 0.16% |
| 2003 FY | 3.03 Billion INR | 9.55% |
| 2002 FY | 2.77 Billion INR | 26.53% |
| 2002 Q3 | 2.69 Billion INR | 4.28% |
| 2002 Q4 | 2.77 Billion INR | 2.74% |
| 2002 Q1 | 2.54 Billion INR | 16.04% |
| 2002 Q2 | 2.58 Billion INR | 1.77% |
| 2001 FY | 2.19 Billion INR | 14.61% |
| 2001 Q1 | 2.45 Billion INR | 0.0% |
| 2001 Q2 | 2.52 Billion INR | 2.81% |
| 2001 Q4 | 2.19 Billion INR | -16.81% |
| 2001 Q3 | 2.63 Billion INR | 4.34% |
| 2000 FY | 1.91 Billion INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Aarey Drugs & Pharmaceuticals Limited | 346.75 Million INR | -18227.514% |
| Aarti Drugs Limited | 4.85 Billion INR | -1207.95% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | -888.582% |
| Ajanta Pharma Limited | 8.28 Billion INR | -667.203% |
| Alembic Limited | 113.4 Million INR | -55942.328% |
| Alkem Laboratories Limited | 26.61 Billion INR | -138.811% |
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | -286.678% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | -2688.812% |
| Bal Pharma Limited | 878.11 Million INR | -7137.329% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -249152.853% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -5265.424% |
| Brooks Laboratories Limited | 96.1 Million INR | -66025.609% |
| Bafna Pharmaceuticals Limited | 296.41 Million INR | -21339.994% |
| Caplin Point Laboratories Limited | 3.63 Billion INR | -1650.551% |
| Divi's Laboratories Limited | 31.84 Billion INR | -99.598% |
| Eris Lifesciences Limited | 1.89 Billion INR | -3261.97% |
| Granules India Limited | 13 Billion INR | -388.657% |
| Ind-Swift Limited | 640.91 Million INR | -9815.823% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -42276.475% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | -1164.691% |
| Jubilant Pharmova Limited | 12.89 Billion INR | -392.804% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -159258.074% |
| Medicamen Biotech Limited | 593.75 Million INR | -10603.459% |
| Medico Remedies Limited | 163.37 Million INR | -38800.179% |
| Wockhardt Limited | 6.4 Billion INR | -893.0% |
| Orchid Pharma Limited | 2.64 Billion INR | -2305.213% |
| RPG Life Sciences Limited | 1.01 Billion INR | -6192.277% |
| Shilpa Medicare Limited | 3.44 Billion INR | -1742.471% |
| Sigachi Industries Limited | 707.2 Million INR | -8886.336% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | -1666.806% |
| Unichem Laboratories Limited | 7.04 Billion INR | -801.861% |
| Vaishali Pharma Limited | 3.79 Million INR | -1673642.428% |
| Wanbury Limited | 360.23 Million INR | -17541.964% |
| Zydus Lifesciences Limited | 34.41 Billion INR | -84.642% |
| FDC Limited | 3.88 Billion INR | -1534.195% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -21886.736% |
| Bajaj HealthCare Limited | 1.44 Billion INR | -4312.163% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | -853.388% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -60670.533% |
| Laurus Labs Limited | 18.45 Billion INR | -244.379% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -5040.092% |
| Nectar Lifesciences Limited | 7.09 Billion INR | -796.17% |
| Par Drugs and Chemicals Limited | 41.77 Million INR | -152047.474% |
| Hester Biosciences Limited | 755.81 Million INR | -8308.462% |
| Ipca Laboratories Limited | 24.71 Billion INR | -157.159% |
| Venus Remedies Limited | 1.21 Billion INR | -5122.45% |
| ZIM Laboratories Limited | 812.62 Million INR | -7720.543% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 35.205% |
| Morepen Laboratories Limited | 2.48 Billion INR | -2456.455% |
| Neuland Laboratories Limited | 3.5 Billion INR | -1713.585% |
| Sequent Scientific Limited | 3.46 Billion INR | -1735.532% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | -2648.84% |
| Valiant Laboratories Limited | 100.15 Million INR | -63354.28% |
| Windlas Biotech Limited | 621.89 Million INR | -10119.171% |
| Hikal Limited | 3.03 Billion INR | -1992.454% |
| Innova Captab Limited | 1.44 Billion INR | -4312.843% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -5724.581% |
| Themis Medicare Limited | 705.74 Million INR | -8904.978% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | -1395.904% |
| Mankind Pharma Limited | 15.53 Billion INR | -309.099% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | -152.888% |
| Sakar Healthcare Limited | 277.32 Million INR | -22816.238% |
| Albert David Limited | 436.12 Million INR | -14472.103% |
| Lupin Limited | 49.53 Billion INR | -28.287% |
| Gufic Biosciences Limited | 2 Billion INR | -3069.959% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 35.6% |
| Lincoln Pharmaceuticals Limited | 771.68 Million INR | -8135.527% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -30045.862% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | -178.859% |
| NATCO Pharma Limited | 7 Billion INR | -807.238% |
| Suven Life Sciences Limited | 7.08 Million INR | -896893.649% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -64772.81% |
| Strides Pharma Science Limited | 11.26 Billion INR | -464.285% |
| Indoco Remedies Limited | 3.53 Billion INR | -1700.034% |
| Alpa Laboratories Limited | 136.65 Million INR | -46406.114% |
| Lasa Supergenerics Limited | 190.43 Million INR | -33272.192% |
| Sun Pharma Advanced Research Company Limited | 14.79 Million INR | -429537.642% |